Entact Bio is a preclinical stage biotechnology company developing a new class of drugs that enhance the function of beneficial proteins. Launched by a founding team deeply rooted in deubiquitinase (DUB) biochemistry, chemical biology, disease biology, and small-molecule drug development, Entact has designed its proprietary Encompass™ platform to create enhancement-targeting chimeric (ENTAC™) medicines. ENTACs harness the ability of DUBs to regulate proteins. By leveraging this natural cellular mechanism to enhance protein function, Entact is expanding the universe of treatable diseases.

Principal Scientist/Associate Director Proteomics

Entact Bio

Director, Biological Sciences

Scientist

Research Scientist

Scientific Associate II

Mechanistic Biology Co-op

Volunteer

Intern

Principal Scientist

Senior Scientist

Postdoctoral Research Fellow

Postdoctoral Research Fellow ♦ Lab Manager

Senior Associate Scientist

Research Associate

Research Assistant

Commercial

Executive Office Manager

Sr. Operations Specialist

Office Manager/ Executive Assistant

Funder/ Pre-Closing Loan Auditor

Discloser Associate

Administrative Assistant/ Social Media Manager

Student Assistant

Principal Scientist, Head of Structural Sciences

Assistant Professor at Center for the Genetics of Host Defense

Postdoctoral Researcher at Center for the Genetics of Host Defense

Postdoctoral Fellow at Department of Biophysics

Director, Data Science

Associate Director, Computational Biology

Associate Director, Bioinformatics / Computational Biology

Senior Scientist, Computational Biologist

Scientist II

Principal Research Associate

Senior Research Associate

Greenhouse.io

Remote

VP, Program Biology

Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients' lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on delivering oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Kymera is also progressing degrader oncology programs that target undrugged or poorly drugged proteins to create new ways to fight cancer. Founded in 2016, Kymera has been recognized as one of Boston's top workplaces for the past several years.

Principal Scientist, Analytical Development

Senior Clinical Trial Associate

Vice President, Immunology Translational Medicine

Director, Clinical Operations

Kymera Therapeutics

DNS Made Easy

Outlook

WP Engine

Adobe Marketing Cloud

Google Analytics

BugHerd

Senior Director, Oncology

Blueprint Medicines is a Massachusetts-based biotechnology company that develops and commercializes precision therapies for the treatment of cancer.

Senior Engineer I

Scientist I, Biology

Quality Document Control Specialist, Contractor I

Blueprint Medicines

Salesforce

Route 53

Sendgrid

Mimecast

Microsoft Office 365

Director, Biology

Senior Scientist II

Agios is a biopharmaceutical company that is fueled by connections. We are passionately committed to applying our leadership in the field of cellular metabolism to create life-changing therapies for people living with rare diseases. The bonds we build with patient communities, healthcare professionals, partners and colleagues help elevate our thinking and propel our science to new heights. These connections, combined with our cellular metabolism expertise, have fueled the development and approval of our first-in-class pyruvate kinase (PK) activator, as well as other investigational therapies. We're a company that cares about our work, each other, and the people who are counting on us the most. We're inspired to think big and welcome the different perspectives and backgrounds needed to deliver extraordinary results.

Associate Director, Global Safety Lead

Executive Assistant

Sr. Manager, Safety Systems Lead

Director, Commercial Strategy & Execution

Agios Pharmaceuticals

CSC Corporate Domains

Rackspace MailGun

ServiceNow

MailChimp SPF

Google Cloud Hosting

Harvard University is devoted to excellence in teaching, learning, and research, and to developing leaders in many disciplines who make a difference globally. Founded in 1636, Harvard is the oldest institution of higher learning in the United States.The official flagship Harvard social media channels are maintained by Harvard Public Affairs and Communications and aim to provide access to the people, places, events, news and research at our Institution. We ask that all visitors to Harvard's digital spaces be civil to one another and to the site editors. Personal attacks, profanity, commercial solicitations, spam, misinformation or other inappropriate contributions are grounds for comment removal. We ask that you stay on topic when contributing to a discussion and refrain from duplicate posts.Hateful or discriminatory comments regarding race, ethnicity, religion, gender, disability, sexual orientation, or political beliefs will not be tolerated. The page administrators reserve the right to delete inappropriate or abusive comments and to permanently ban or block users from the Harvard social media accounts.

Stefanie Schalm

VP, Program Biology at Entact Bio

Stefanie Schalm's Professional Contact Details

Stefanie Schalm's Current Company Details

Entact Bio

Stefanie Schalm's Work History and Education

Frequently Asked Questions about Stefanie Schalm

What company does Stefanie Schalm work for?

What is Stefanie Schalm's role at Entact Bio?

What is Stefanie Schalm's email address?

What is Stefanie Schalm's business email address?

What is Stefanie Schalm's direct mobile number?

What is Stefanie Schalm's HQ phone number?

What industry does Stefanie Schalm work in?

Who are Stefanie Schalm's colleagues?

Colleagues at Entact Bio

Prospect on LinkedIn

People Search

Company Search

Erik Straub

Michael Transon

Ready to try it out?